换一批Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation.
第一作者：
Yuhong,Chen
第一单位：
Peking University People's Hospital, Peking University Institute of Haematology, Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Collaborative Innovation Centre of Haematology, Peking University, Beijing, China.
作者：
医学主题词
青少年(Adolescent);成年人(Adult);抗原, CD19(Antigens, CD19);儿童(Child);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);单倍型(Haplotypes);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);男(雄)性(Male);肿瘤, 残余(Neoplasm, Residual);前体B细胞淋巴母细胞白血病淋巴瘤(Precursor B-Cell Lymphoblastic Leukemia-Lymphoma);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);缓解诱导(Remission Induction);挽救疗法(Salvage Therapy);T淋巴细胞(T-Lymphocytes);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1111/bjh.14923
PMID
29076142
发布时间
2018-02-09
- 浏览14
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
